Aridis Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.03.23	Aridis Pharma Says Phase 2a Study Of AR-501 In Cystic Fibrosis Meets Endpoints (RTTNews)
17.02.22	Why Aridis Pharma Is Rising In Pre-market? (RTTNews)
27.01.22	Aridis Gets $1.9 Mln Funding From Gates Foundation To Fight Influenza, Covid-19 In Poor Countries (RTTNews)
30.12.21	Pre-market Movers: KPRX, CTK, VGR, BVXV, NEW… (RTTNews)
27.12.21	Pre-market Movers: SKM, ICCM, BVXV, AVCT, GNCA… (RTTNews)
21.12.21	Pre-market Movers: ARDS, RELI, ALDX, QNRX, AQST… (RTTNews)
21.12.21	Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19 Variants, SARS, MERS, and the Common Cold Hum... (PR Newswire)
12.08.21	Aridis Pharmaceuticals Announces Second Quarter 2021 Results (PR Newswire)
26.07.21	Aridis Pharmaceuticals' COVID mAb Ranks Among the Top 5 Most Potent COVID-19 mAbs Evaluated by the Coronavirus Immunotherapeutics Consortium (CoVIC) (PR Newswire)
19.07.21	Aridis Acquires Rights For Development And Commercialization Of Suvratoxumab (RTTNews)
19.07.21	Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase 3-Ready Monoclonal Antibody, from AstraZeneca (PR Newswire)
13.07.21	Aridis Pharma Says AR-712 Neutralizes Covid-19 Delta Variant (RTTNews)
12.07.21	Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant (PR Newswire)
14.07.20	EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4 (RTTNews)
06.05.20	ARDS In COVID-19 Battle, AKBA's Kidney Disease Drug Hits Goals, VAPO On A Roll (RTTNews)
07.01.20	Aridis Pharma Up Over 30% In 3 Trading Days, Awaits Phase 3 Data In Early 2020 (RTTNews)
02.01.20	Aridis Pharma: Michael Nazak Succeeds Fred Kurland As CFO, Effective Jan. 1 (RTTNews)
31.12.19	ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed (RTTNews)
28.08.19	6 Top Gainers In Healthcare Sector (PSTV, PRTA, ARDS…) (RTTNews)
27.08.19	5 Top Gainers In Healthcare Sector (ARDS, PSTV, SLRX…) (RTTNews)
15.08.19	This Day That Year: Aridis Pharma (RTTNews)
27.06.19	Aridis Pharma Granted Orphan Drug Designation For AR-501 By FDA - Quick Facts (RTTNews)
29.03.19	ARDS On The Move, GLPG Reports Positive Data, PRTO Plunges On PATENCY-2 Results (RTTNews)
12.03.19	8 Top Gainers In Healthcare Sector (BPTH, ORGO, PTE...) (RTTNews)
13.12.18	GLMD On Watch, ARDS On The Move, MDCO Gets New CEO (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	81.42	1.90 %	K V
Part Grp Hldg	1’396.50	1.12 %	K V
Lonza Grp	586.80	1.10 %	K V
Novartis	90.45	0.80 %	K V
Kuehne+Nagel Int	206.10	0.73 %	K V
Sika	228.00	-0.18 %	K V
ABB	53.42	-0.26 %	K V
Givaudan	3’922.00	-0.58 %	K V
Geberit	497.60	-0.64 %	K V
Sonova Hldg	314.60	-1.22 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Aridis Pharmaceuticals Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten